Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion type Assertion NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_head.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion description "[In order to clarify the significance of p16 gene (CDKN2) inactivation and its disease specificity among hematopoietic tumors, configurations of the p16 gene as well as those of the adjacent p15 and interferon alpha (IFN alpha) genes were examined in primary hematopoietic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_provenance.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion evidence source_evidence_literature NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_provenance.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion SIO_000772 9209389 NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_provenance.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion wasDerivedFrom befree-20140225 NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_provenance.
- NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_assertion wasGeneratedBy ECO_0000203 NP584370.RAbwsSv1dy9zd3C257ntaBYACroLIOZ9R1J5Mj_tmkDNc130_provenance.